CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Authors
A Amalfitano
A Amalfitano
+50 more
AC Hobeika
AC Hobeika
Adrian Rice
AH Cory
Arvind Chaudhry
BG Wieking
C Palena
CS Higano
CS Karapetis
D Hartigan-O’Connor
DH Barouch
DJ Jonker
DS Bangari
E Cutsem Van
EA Eisenhauer
EJ Small
Elizabeth S. Gabitzsch
ES Gabitzsch
ES Gabitzsch
ES Gabitzsch
ES Gabitzsch
ES Gabitzsch
ES Gabitzsch
ES Gabitzsch
FH Rininsland
FR Jones
Frank R. Jones
Gerald L. Messerschmidt
J Schlom
JA Thompson
Joseph P. Balint
K Shafer-Weaver
M Beyer
M Vergati
MA Cheever
Michael A. Morse
MM Morse
N Chirmule
N Tatsis
NL Berinstein
PW Kantoff
S Hammarstrom
S Tangri
S Zaremba
SK Campos
SR Gameiro
SS Seregin
T Osada
Younong Xu
Yvette Latchman
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs00262-015-...
Last time updated on 02/01/2020